companydata.dkcompanydata.dk

Thermo Fisher Diagnostics ApS: Financial statements 2020

CVR: 27640745

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Thermo Fisher Diagnostics ApS (CVR 27640745) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 34,651,000 and a net result of DKK 5,002,000 compared with DKK 7,544,000 the year before. That is a decrease of 3.5% compared with the year before. Equity in the 2020 report amounted to DKK 42,664,000. The solvency ratio was 54.8%. The company had 35 employees in the financial year.

Gross Profit
DKK 34,651,000
Profit/Loss
DKK 5,002,000
Equity
DKK 42,664,000
Total Assets
DKK 77,865,000
Employees
35

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-34.7M5M42.7M35
2019-35.9M7.5M37.7M31
2018-34.6M8.4M30.1M27
2017-27.1M5M21.7M22
2016-13.6M2.6M16.7M11

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Thermo Fisher Diagnostics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Bo Kühnel Matthisson joins the board of Thermo Fisher Diagnostics ApSDec 23, 2020

As of December 23, 2020, Bo Kühnel Matthisson has joined the board of directors of Thermo Fisher Diagnostics ApS.

Grant Hellier Lawrence leaves the board of Thermo Fisher Diagnostics ApSDec 23, 2020

As of December 23, 2020, Grant Hellier Lawrence has left the board of directors of Thermo Fisher Diagnostics ApS.

Thermo Fisher Diagnostics ApS: The 2019 annual report is outJun 26, 2020

Thermo Fisher Diagnostics ApS has published its annual report for 2019. Gross profit came to DKK 35,896,000, and the net result was DKK 7,544,000.

About Thermo Fisher Diagnostics ApS

Thermo Fisher Diagnostics ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2004. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named PHADIA ApS and SWEDEN DIAGNOSTICS (DENMARK), ApS. The management consists of Pia Finnemann-Andersen. The board consists of Petrus Thomas Adrianus van der Zande (chair), Pia Finnemann-Andersen and Simon Lie. The company is owned by Thermo Fisher Scientific Beteiligungsverwaltungs GmbH. The company has 24 employees (2026). In 2025, the company reported a gross profit of DKK 34,059,000 and a net result of DKK 5,450,000 compared with DKK 6,358,000 the year before. Equity in the 2025 report amounted to DKK 74,863,000.

Source: annual report 2025, Danish Business Authority